Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors–Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment

by Yoshie Yoshikawa, Kozo Kuribayashi, Toshiyuki Minami, Masaki Ohmuraya, Takashi Kijima
Published 2020-12-01

Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma

by Yasuhiro Nakajima, Takeshi Kanno, Toshio Nagaya, Kozo Kuribayashi, Takashi Nakano, Akinobu Gotoh, Tomoyuki Nishizaki
Published 2015-01-01

Usefulness of Quantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography for Evaluating the Treatment Response of Bone Metastasis in a Lung Cancer Patient

by Kazuhiro Kitajima, Tatsuya Tsuchitani, Yoshiyuki Takahashi, Toshiyuki Minami, Takashi Yokoi, Akifumi Nakamura, Masaki Hashimoto, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa, Koichiro Yamakado
Published 2021-03-01

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT

by Kazuhiro Kitajima, Mitsunari Maruyama, Hiroyuki Yokoyama, Toshiyuki Minami, Takashi Yokoi, Akifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa, Koichiro Yamakado
Published 2021-03-01

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report

by Eriko Fujimoto, Takashi Yokoi, Koji Mikami, Shingo Kanemura, Eisuke Shibata, Daisuke Horio, Yuichi Koda, Yoshiki Negi, Yumiko Akano, Akio Tada, Toshiyuki Minami, Kozo Kuribayashi, Takashi Kijima
Published 2018-05-01